期刊
LANCET
卷 381, 期 9867, 页码 670-679出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(12)62089-3
关键词
-
资金
- Abbott
- Amgen
- AstraZeneca
- GeorgeClinical
- GlaxoSmithKline
- Novartis
- PepsiCo
- Pfizer
- Pharmacy Guild of Australia
- Roche
- Sanofi-Aventis
- Servier
- Tanabe
- Australian Food and Grocery Council
- Bupa Australia
- Johnson and Johnson
- Merck Schering Plough
- United Healthcare Group
- Australian Research Council
- Medical Research Council [MR/K023195/1, MR/K023195/1B] Funding Source: researchfish
The 2011 UN high-level meeting on non-communicable diseases (NCDs) called for multisectoral action including with the private sector and industry. However, through the sale and promotion of tobacco, alcohol, and ultra-processed food and drink (unhealthy commodities), transnational corporations are major drivers of global epidemics of NCDs. What role then should these industries have in NCD prevention and control? We emphasise the rise in sales of these unhealthy commodities in low-income and middle-income countries, and consider the common strategies that the transnational corporations use to undermine NCD prevention and control. We assess the effectiveness of self-regulation, public-private partnerships, and public regulation models of interaction with these industries and conclude that unhealthy commodity industries should have no role in the formation of national or international NCD policy. Despite the common reliance on industry self-regulation and public-private partnerships, there is no evidence of their effectiveness or safety. Public regulation and market intervention are the only evidence-based mechanisms to prevent harm caused by the unhealthy commodity industries.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据